A novel mechanism involved in 5-hydroxytryptamine-induced nociception: The indirect activation of primary afferents

Neuroscience

Volumn 141, Issue 3, 2006, Pages 1517-1524

  Tambeli, C H ^a   Oliveira, M C G ^a   Clemente, J T ^a   Pelegrini da Silva, A ^a   Parada, C A ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

adrenoceptors; dopamine; norepinephrine; pain; prostaglandin; serotonin

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; FUCOIDIN; GUANETHIDINE; INDOMETACIN; NORADRENALIN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN INHIBITOR; SELECTIN; SEROTONIN; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; TROPISETRON;

ADRENERGIC SYSTEM; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; HYPOTHESIS; INFLAMMATORY CELL; MALE; MUSCLE SPINDLE AFFERENT NERVE; NEUTROPHIL; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT; RECEPTOR BLOCKING;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ADRENERGIC BETA-ANTAGONISTS; AFFERENT PATHWAYS; ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; ATENOLOL; BEHAVIOR, ANIMAL; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; INDOMETHACIN; MALE; NEUTROPHILS; NOCICEPTORS; PAIN; PAIN MEASUREMENT; POLYSACCHARIDES; PROPANOLAMINES; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN AGENTS; TIME FACTORS;

EID: 33746619635     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.04.030     Document Type: Article

References (53)

1. Abbott F.V., Hong Y., and Blier P. Activation of 5-HT2A receptors potentiates pain produced by inflammatory mediators. Neuropharmacology 35 (1996) 99-110
2. th International Congress of Pharmacology (1984), Scientific & Medical Division, Macmillan Press Ltd, London 231
3. Bertrand A., and Weil-Fugazza J. Sympathectomy does not modify the levels of dopa or dopamine in the rat dorsal root ganglion. Brain Res 681 (1995) 201-204
4. Birrell G.J., McQueen D.S., Iggo A., and Grubb B.D. The effects of 5-HT on articular sensory receptors in normal and arthritic rats. Br J Pharmacol 101 (1990) 715-721
5. Boullin D.J., Costa E., and Brodie B.B. Discharge of tritium-labeled guanethidine by sympathetic nerve stimulation as evidence that guanethidine is a false transmitter. Life Sci 5 (1960) 803-808
6. Bradley P.P., Priebat D.A., Christensen R.D., and Rothstein G. Measurement of cutaneous inflammation. estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78 (1982) 206-209
7. Claria J., and Romano M. Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer. Curr Pharm Des 11 (2005) 3431-3447
8. Cunha F.Q., Lorenzetti B.B., Poole S., and Ferreira S.H. Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol 104 (1991) 765-767
9. Cunha F.Q., Poole S., Lorenzetti B.B., and Ferreira S.H. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 107 (1992) 660-664
10. Doak G.J., and Sawynok J. Formalin-induced nociceptive behavior and edema. involvement of multiple peripheral 5-hydroxytryptamine receptor subtypes. Neuroscience 80 (1997) 939-949
11. Dray A. Inflammatory mediators of pain. Br J Anaesth 75 (1995) 125-131
12. Ernberg M., Lundeberg T., and Kopp S. Pain and allodynia/hyperalgesia induced by intramuscular injection of serotonin in patients with fibromyalgia and healthy individuals. Pain 85 (2000) 31-39
13. Facchinetti F., Del Giudice E., Furegato S., Passarotto M., Arcidiacono D., and Leon A. Dopamine inhibits responses of astroglia-enriched cultures to lipopolysaccharide via a beta-adrenoreceptor-mediated mechanism. J Neuroimmunol 150 (2004) 29-36
14. Fasano M.B., Wells J.D., and McCall C.E. Human neutrophils express the prostaglandin G/H synthase 2 gene when stimulated with bacterial lipopolysaccharide. Clin Immunol Immunopathol 87 (1998) 304-308
15. Ferreira S.H., Nakamura M., and de Abreu Castro M.S. The hyperalgesic effects of prostacyclin and prostaglandin E2. Prostaglandins 16 (1978) 31-37
16. Green P.G., Luo J., Heller P.H., and Levine J.D. Further substantiation of a significant role for the sympathetic nervous system in inflammation. Neuroscience 55 (1993) 1037-1043
17. Holz IV G.G., and Anderson E.G. The actions of serotonin on frog primary afferent terminals and cell bodies. Comp Biochem Physiol C 77 (1984) 13-21
18. Holz IV G.G., Shefner S.A., and Anderson E.G. Serotonin depolarizes type A and C primary afferents. an intracellular study in bullfrog dorsal root ganglion. Brain Res 327 (1985) 71-79
19. Hong Y., and Abbott F.V. Behavioural effects of intraplantar injection of inflammatory mediators in the rat. Neuroscience 63 (1994) 827-836
20. Inoue M., Rashid M.H., Kawashima T., Matsumoto M., Maeda T., Kishioka S., and Ueda H. The algogenic-induced nociceptive flexion test in mice. studies on sensitivity of the test and stress on animals. Brain Res Bull 60 (2003) 275-281
21. Jackson J.C., Walker R.F., Brooks W.H., and Roszman T.L. Specific uptake of serotonin by murine macrophages. Life Sci 42 (1988) 1641-1650
22. Johnson Jr. E.M., Cantor E., and Douglas J.R. Biochemical and functional evaluation of the sympathectomy produced by the administration of guanethidine to newborn rats. J Pharmacol Exp Ther 193 2 (1975) 503-512
23. Kress M., and Reeh P.W. More sensory competence for nociceptive neurons in culture. Proc Natl Acad Sci U S A 93 (1996) 14995-14997
24. Kubera M., Maes M., Kenis G., Kim Y.K., and Lason W. Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6. Psychiatry Res 134 (2005) 251-258
25. Levine J.D., Dardick S.J., Roizen M.F., Helms C., and Basbaum A.I. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci 6 (1986) 3423-3429
26. Malone H.M., Peters J.A., and Lambert J.J. Physiological and pharmacological properties of 5-HT3 receptors-a patch clamp-study. Neuropeptides 19 Suppl: (1991) 25-30
27. Maxwell R.A., Plummer A.J., Schneider F., Povalski H., and Daniel A.I. Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864). J Pharmacol Exp Ther 128 (1960) 22-29
28. Meuser T., Pietruck C., Gabriel A., Xie G.X., Lim K.J., and Pierce Palmer P. 5-HT7 receptors are involved in mediating 5-HT-induced activation of rat primary afferent neurons. Life Sci 71 (2002) 2279-2289
29. Mossner R., and Lesch K.P. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immunol 12 (1998) 249-271
30. Nakamura M., and Ferreira S.H. A peripheral sympathetic component in inflammatory hyperalgesia. Eur J Pharmacol 135 (1987) 145-153
31. Okamoto K., Imbe H., Morikawa Y., Itoh M., Sekimoto M., Nemoto K., and Senba E. 5-HT2A receptor subtype in the peripheral branch of sensory fibers is involved in the potentiation of inflammatory pain in rats. Pain 99 (2002) 133-143
32. Oliveira M.C., Parada C.A., Veiga M.C., Rodrigues L.R., Barros S.P., and Tambeli C.H. Evidence for the involvement of endogenous ATP and P2X receptors in TMJ pain. Eur J Pain 9 (2005) 87-93
33. Parada C.A., Tambeli C.H., Cunha F.Q., and Ferreira S.H. The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience 102 (2001) 937-944
34. Parada C.A., Yeh J.J., Joseph E.K., and Levine J.D. Tumor necrosis factor receptor type-1 in sensory neurons contributes to induction of chronic enhancement of inflammatory hyperalgesia in rat. Eur J Neurosci 17 (2003) 1847-1852
35. Philippe E., Zhou C., Audet G., Geffard M., and Gaulin F. Expression of dopamine by chick primary sensory neurons and their related targets. Brain Res Bull 30 (1993) 227-230
36. Price J., and Mudge A.W. A subpopulation of rat dorsal root ganglion neurones is catecholaminergic. Nature 301 (1983) 241-243
37. Richardson B.P., Engel G., Donatsch P., and Stadler P.A. Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature 316 (1985) 126-131
38. Rosland J.H. The formalin test in mice. the influence of ambient temperature. Pain 45 (1991) 211-216
39. Roveroni R.C., Parada C.A., Cecilia M., Veiga F.A., and Tambeli C.H. Development of a behavioral model of TMJ pain in rats. the TMJ formalin test. Pain 94 (2001) 185-191
40. Roy B., and Rai U. Dual mode of catecholamine action on splenic macrophage phagocytosis in wall lizard, Hemidactylus flaviviridis. Gen Comp Endocrinol 136 (2004) 180-191
41. Rueff A., and Dray A. 5-Hydroxytryptamine-induced sensitization and activation of peripheral fibres in the neonatal rat are mediated via different 5-hydroxytryptamine-receptors. Neuroscience 50 (1992) 899-905
42. Sawynok J. Topical and peripherally acting analgesics. Pharmacol Rev 55 (2003) 1-20
43. Secco D.D., Paron J.A., de Oliveira S.H., Ferreira S.H., Silva J.S., and de Cunha F.Q. Neutrophil migration in inflammation. nitric oxide inhibits rolling, adhesion and induces apoptosis. Nitric Oxide 9 (2003) 153-164
44. Seide M.F., Ulrich-Merzenich G., Fiebich B., Candelario-Jalil E., Koch F.W., and Vetter H. Tropisetron inhibits serotonin-induced PGE2 release from macrophage-like synovial cells in serum-free tissue culture. Scand J Rheumatol Suppl 119 (2004) 33
45. Sommer C. Serotonin in pain and analgesia. actions in the periphery. Mol Neurobiol 30 2 (2004) 117-125
46. Sufka K.J., Schomburg F.M., and Giordano J. Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol Biochem Behav 41 (1992) 53-56
47. Taiwo Y.O., and Levine J.D. Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience 44 (1991) 131-135
48. Taiwo Y.O., and Levine J.D. Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience 48 (1992) 485-490
49. Waldron J.B., and Sawynok J. Peripheral P2X receptors and nociception. interactions with biogenic amine systems. Pain 110 (2004) 79-89
50. Weissmann G. The biochemistry of inflammation. rheumatoid arthritis and anti-inflammatory drugs. J Miss State Med Assoc 23 (1982) 66-73
51. Wheeler-Aceto H., Porreca F., and Cowan A. The rat paw formalin test. comparison of noxious agents. Pain 40 (1990) 229-238
52. Zhang X.W., Liu Q., and Thorlacius H. Inhibition of selectin function and leukocyte rolling protects against dextran sodium sulfate-induced murine colitis. Scand J Gastroenterol 36 (2001) 270-275
53. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110